精品国产污污免费网站,欧美XXXX做受欧美88,午夜毛片不卡免费观看视频,欧美高潮喷水大叫

2023

Utidelone recommended by “2023 CSCO Guidelines for Diagnosis and Treatment of Breast Cancer” as Class I

查看大圖
2022

UTD1 Phase 3 INDs approved by NMPA for NSCLC and BC neoadjuvant; UTD2 Phase 1 INDs approved by FDA and NMPA

查看大圖
2023

Utidelone listed in “China's national reimbursement drug list”

查看大圖
2022

Biostar Pharma, Inc. (US subsidiary) incorporated

查看大圖
2021

Extraordinary general meeting held and share-holding reform completed

查看大圖
2021

Utidelone Injectable NDA approval for the first indication of advanced breast cancer

查看大圖
2020

Pre-IPO financing of 890 million RMB

查看大圖
2018

Utidelone Injectable NDA submission as priority review

查看大圖
2017

Chengdu manufacturing base established for microbial fermentation production and drug product manufacturing

查看大圖
2016

Utidelone Injectable Phase 3 reached the primary endpoint

查看大圖
2015

Wholly-owned subsidiary incorporated in Chengdu

查看大圖
2012

R&D center established covering key biosynthesis platforms

查看大圖
2011

Utidelone Injectable Phase 2/3 IND approved

查看大圖
2007

Utidelone injectable Phase 1 IND approved

查看大圖
2002

Beijing Biostar Pharmaceuticals incorporated in Beijing China

查看大圖
国产精品亚洲二区在线观看| 国产成人综合色就色综合| 成人网站精品久久久久| 免费的行情软件APP网站九幺| 日韩中文人妻无码不卡| 国产精品18久久久久久麻辣|